Effect of Pioglitazone on T2DM Patients With COVID-19

Clinical trial NCT04604223 · UNKNOWN

Trial details

NCT number: NCT04604223
Sponsor: Dasman Diabetes Institute
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Covid19 Type 2 Diabetes

Start date: 2021-01-18
Primary completion: 2021-06-29
Enrollment: 1506

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.